- Home
- SINT vs BIAF Comparison
SINT vs BIAF Comparison
Compare SINT & BIAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SINT
- BIAF
- Stock Information
- Founded
- SINT 1996
- BIAF 2014
- Country
- SINT United States
- BIAF United States
- Employees
- SINT N/A
- BIAF N/A
- Industry
- SINT Medical/Dental Instruments
- BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- SINT Health Care
- BIAF Health Care
- Exchange
- SINT Nasdaq
- BIAF Nasdaq
- Market Cap
- SINT 8.3M
- BIAF 7.1M
- IPO Year
- SINT 2014
- BIAF 2022
- Fundamental
- Price
- SINT $5.51
- BIAF $0.24
- Analyst Decision
- SINT Strong Buy
- BIAF Hold
- Analyst Count
- SINT 1
- BIAF 1
- Target Price
- SINT $28.00
- BIAF N/A
- AVG Volume (30 Days)
- SINT 2.1M
- BIAF 468.1K
- Earning Date
- SINT 08-14-2025
- BIAF 08-14-2025
- Dividend Yield
- SINT N/A
- BIAF N/A
- EPS Growth
- SINT N/A
- BIAF N/A
- EPS
- SINT N/A
- BIAF N/A
- Revenue
- SINT $1,861,000.00
- BIAF $7,681,059.00
- Revenue This Year
- SINT N/A
- BIAF N/A
- Revenue Next Year
- SINT $87.50
- BIAF $20.00
- P/E Ratio
- SINT N/A
- BIAF N/A
- Revenue Growth
- SINT N/A
- BIAF 4.99
- 52 Week Low
- SINT $1.71
- BIAF $0.16
- 52 Week High
- SINT $8.60
- BIAF $2.26
- Technical
- Relative Strength Index (RSI)
- SINT 72.95
- BIAF 39.54
- Support Level
- SINT $3.10
- BIAF $0.24
- Resistance Level
- SINT $6.78
- BIAF $0.26
- Average True Range (ATR)
- SINT 0.63
- BIAF 0.02
- MACD
- SINT 0.19
- BIAF 0.00
- Stochastic Oscillator
- SINT 66.34
- BIAF 17.02
About SINT SiNtx Technologies Inc.
SINTX Technologies Inc is a ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming a renowed ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have good bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.
About BIAF bioAffinity Technologies Inc.
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.